Literature DB >> 34406229

Post COVID-19 vaccine adenopathy: first Brazilian report.

Joshua Araújo Viana1,2, Eduardo Kaiser Ururahy Nunes Fonseca1,2, Márcio Valente Yamada Sawamura1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34406229      PMCID： PMC8352761          DOI： 10.36416/1806-3756/e20210206

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  3 in total

Review 1.  Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel.

Authors:  Anton S Becker; Rocio Perez-Johnston; Sona A Chikarmane; Melissa M Chen; Maria El Homsi; Kimberly N Feigin; Katherine M Gallagher; Ehab Y Hanna; Marshall Hicks; Ahmet T Ilica; Erica L Mayer; Atul B Shinagare; Randy Yeh; Marius E Mayerhoefer; Hedvig Hricak; H Alberto Vargas
Journal:  Radiology       Date:  2021-02-24       Impact factor: 11.105

2.  Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.

Authors:  Yael Eshet; Noam Tau; Yousef Alhoubani; Nayroz Kanana; Liran Domachevsky; Michal Eifer
Journal:  Radiology       Date:  2021-04-27       Impact factor: 11.105

3.  Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.

Authors:  Can Özütemiz; Luke A Krystosek; An L Church; Anil Chauhan; Jutta M Ellermann; Evidio Domingo-Musibay; Daniel Steinberger
Journal:  Radiology       Date:  2021-02-24       Impact factor: 11.105
  3 in total
  1 in total

Review 1.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.

Authors:  Jihe Lim; Seun Ah Lee; Eun Kyung Khil; Sun-Ju Byeon; Hee Joon Kang; Jung-Ah Choi
Journal:  Semin Oncol       Date:  2021-10-26       Impact factor: 4.929
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.